Nkarta, Inc. Other Nonoperating Income (Expense)
Nkarta, Inc. (NKTX) reported Other Nonoperating Income (Expense) of $222.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-10
- Nkarta, Inc. other nonoperating income (expense) for the quarter ending 2026-06-30 was $222.00K, a 7.11% decline year-over-year.
- Nkarta, Inc. other nonoperating income (expense) for the quarter ending 2026-03-31 was $206.00K, a 0.49% increase year-over-year.
- Nkarta, Inc. other nonoperating income (expense) for the quarter ending 2025-12-31 was $256.00K, a 172.34% increase year-over-year.
- Nkarta, Inc. other nonoperating income (expense) for the quarter ending 2025-09-30 was $1.72M.
- Nkarta, Inc. other nonoperating income (expense) for fiscal 2025 was $2.42M, a 2680.46% increase from fiscal 2024.
- Nkarta, Inc. other nonoperating income (expense) for fiscal 2024 was $87.00K, a 107.14% increase from fiscal 2023.
- Nkarta, Inc. other nonoperating income (expense) for fiscal 2023 was $42.00K.
- Nkarta, Inc. other nonoperating income (expense) for fiscal 2022 was -$470.00K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $222.00K 10-Q · filed 2026-08-10 | $428.00K 10-Q · filed 2026-08-10 | $684.00K derived: sum of 3 quarters · filed 2026-08-10 | $2.40M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2026-03-31 | $206.00K 10-Q · filed 2026-05-12 | $462.00K derived: sum of 2 quarters · filed 2026-05-12 | $2.18M derived: sum of 3 quarters · filed 2026-05-12 | $2.42M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-12-31 | $256.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.98M derived: sum of 2 quarters · filed 2026-03-25 | $2.21M derived: sum of 3 quarters · filed 2026-08-10 | $2.42M 10-K · filed 2026-03-25 | ||
| 2025-09-30 | $1.72M 10-Q · filed 2025-11-10 | $1.96M derived: sum of 2 quarters · filed 2026-08-10 | $2.16M 10-Q · filed 2025-11-10 | $2.26M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-06-30 | $239.00K 10-Q · filed 2026-08-10 | $444.00K 10-Q · filed 2026-08-10 | $538.00K derived: sum of 3 quarters · filed 2026-08-10 | $535.00K derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-03-31 | $205.00K 10-Q · filed 2026-05-12 | $299.00K derived: sum of 2 quarters · filed 2026-05-12 | $296.00K derived: sum of 3 quarters · filed 2026-05-12 | $294.00K derived: sum of 4 quarters · filed 2026-05-12 | ||
| 2024-12-31 | $94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $91.00K derived: sum of 2 quarters · filed 2026-03-25 | $89.00K derived: sum of 3 quarters · filed 2026-03-25 | $87.00K 10-K · filed 2026-03-25 | ||
| 2024-09-30 | -$3.00K 10-Q · filed 2025-11-10 | -$5.00K derived: sum of 2 quarters · filed 2025-11-10 | -$7.00K 10-Q · filed 2025-11-10 | -$32.00K derived: sum of 4 quarters · filed 2025-11-10 | ||
| 2024-06-30 | -$2.00K 10-Q · filed 2025-08-12 | -$4.00K 10-Q · filed 2025-08-12 | -$29.00K derived: sum of 3 quarters · filed 2025-08-12 | $4.00K derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | -$2.00K 10-Q · filed 2025-05-14 | -$27.00K derived: sum of 2 quarters · filed 2025-05-14 | $6.00K derived: sum of 3 quarters · filed 2025-05-14 | $7.00K derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2023-12-31 | -$25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $8.00K derived: sum of 2 quarters · filed 2025-03-26 | $9.00K derived: sum of 3 quarters · filed 2025-03-26 | $42.00K 10-K · filed 2025-03-26 | ||
| 2023-09-30 | $33.00K 10-Q · filed 2024-11-07 | $34.00K derived: sum of 2 quarters · filed 2024-11-07 | $67.00K 10-Q · filed 2024-11-07 | -$422.00K derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $1.00K 10-Q · filed 2024-08-13 | $34.00K 10-Q · filed 2024-08-13 | -$455.00K derived: sum of 3 quarters · filed 2024-08-13 | -$438.00K derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $33.00K 10-Q · filed 2024-05-09 | -$456.00K derived: sum of 2 quarters · filed 2024-05-09 | -$439.00K derived: sum of 3 quarters · filed 2024-05-09 | -$436.00K derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | -$489.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | -$472.00K derived: sum of 2 quarters · filed 2024-03-21 | -$469.00K derived: sum of 3 quarters · filed 2024-03-21 | -$470.00K 10-K · filed 2024-03-21 | ||
| 2022-09-30 | $17.00K 10-Q · filed 2023-11-09 | $20.00K derived: sum of 2 quarters · filed 2023-11-09 | $19.00K 10-Q · filed 2023-11-09 | $17.00K derived: sum of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | $3.00K 10-Q · filed 2023-08-10 | $2.00K 10-Q · filed 2023-08-10 | $0.00 derived: sum of 3 quarters · filed 2023-08-10 | -$6.00K derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | -$1.00K 10-Q · filed 2023-05-11 | -$3.00K derived: sum of 2 quarters · filed 2023-05-11 | -$9.00K derived: sum of 3 quarters · filed 2023-05-11 | -$14.00K derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$8.00K derived: sum of 2 quarters · filed 2023-03-16 | -$13.00K derived: sum of 3 quarters · filed 2023-03-16 | -$16.00K 10-K · filed 2023-03-16 | ||
| 2021-09-30 | -$6.00K 10-Q · filed 2022-11-09 | -$11.00K derived: sum of 2 quarters · filed 2022-11-09 | -$14.00K 10-Q · filed 2022-11-09 | $133.00K derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | -$5.00K 10-Q · filed 2022-08-11 | -$8.00K 10-Q · filed 2022-08-11 | $139.00K derived: sum of 3 quarters · filed 2022-08-11 | -$14.00K derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | -$2.00K 10-Q · filed 2022-05-12 | $144.00K derived: sum of 2 quarters · filed 2022-05-12 | -$9.00K derived: sum of 3 quarters · filed 2022-05-12 | -$5.00K derived: sum of 4 quarters · filed 2022-05-12 | ||
| 2020-12-31 | $146.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$7.00K derived: sum of 2 quarters · filed 2022-03-17 | -$3.00K derived: sum of 3 quarters · filed 2022-03-17 | -$3.00K 10-K · filed 2022-03-17 | ||
| 2020-09-30 | -$153.00K 10-Q · filed 2021-11-10 | -$149.00K derived: sum of 2 quarters · filed 2021-11-10 | -$149.00K 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | $4.00K 10-Q · filed 2021-08-12 | $4.29K 10-Q · filed 2020-08-20 | $4.00K 10-Q · filed 2021-08-12 | $4.29K 10-Q · filed 2020-08-20 | ||
| 2019-12-31 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $18.00K derived: sum of 2 quarters · filed 2021-03-25 | $18.00K 10-K · filed 2021-03-25 | |||
| 2019-09-30 | $35.00K 10-Q · filed 2020-11-12 | $35.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |